pindolol has been researched along with Eye Disorders in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Beta-blocking drugs differ considerably in their bioavailability because of differences in the rate and extent of metabolism in the first past through the liver after absorption from the gut." | 1.26 | Clinical pharmacology of adrenergic-adrenoreceptor-blocking drugs. ( Jarrott, B; Louis, WJ; McNeil, JJ; Rand, MJ; Taylor, H, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Louis, WJ | 1 |
| Taylor, H | 1 |
| McNeil, JJ | 1 |
| Jarrott, B | 1 |
| Rand, MJ | 1 |
1 other study available for pindolol and Eye Disorders
| Article | Year |
|---|---|
Clinical pharmacology of adrenergic-adrenoreceptor-blocking drugs.
Topics: Adrenergic beta-Antagonists; Biological Availability; Blood Pressure; Double-Blind Method; Drug Eval | 1982 |